Showing results (2631-2640 of 3,872) with videos related to
Sort By:
Pageof 388
Cancer Biology & Therapy|August 27, 2013
The multi-hit hypothesis in basal-like breast cancerPaul DentCancer Biology & Therapy|September 13, 2013
The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicityJianMin Lin, Jared L Spidel, Christopher J Maddage, et al.Cancer Biology & Therapy|September 13, 2013
Treatment of agarose-agarose RENCA macrobeads with docetaxel selects for OCT4(+) cells with tumor-initiating capabilityLawrence S Gazda, Prithy C Martis, Melissa A Laramore, et al.Cancer Biology & Therapy|September 13, 2013
Advances in the understanding of the Fanconi anemia tumor suppressor pathwayAnna Pickering, Jun Zhang, Jayabal Panneerselvam, et al.Cancer Biology & Therapy|September 13, 2013
Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinomaSweta Rani, Kathy Gately, John Crown, et al.Cancer Biology & Therapy|August 7, 2013
Role of microRNA-mediated MMP regulation in the treatment and diagnosis of malignant tumorsLiqin Li, Heng LiCancer Biology & Therapy|August 7, 2013
Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumabNicholas G Zaorsky, Yunguang Sun, Zixuan Wang, et al.Cancer Biology & Therapy|November 17, 2015
Tangeretin derivative, 5-acetyloxy-6,7,8,4'-tetramethoxyflavone induces G2/M arrest, apoptosis and autophagy in human non-small cell lung cancer cells in vitro and in vivoYi Rong Li, Shiming Li, Chi-Tang Ho, et al.Cancer Biology & Therapy|November 18, 2015
Antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutationsDo-Hee Kim, Yeonui Kwak, Nam Doo Kim, et al.Pageof 388